HELEN S BAROLD

Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology ROCKVILLE, MD NPI 1114005238

General Payments — all program years on this page

$127,216.22

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 66
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $396.66 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $396.6615

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $44,771.388
2019 $81,428.5010
2020 $55.553
2021 $204.3812
2022 $186.9210
2023 $172.838
2024 $396.6615

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078046210 Janssen Pharmaceuticals, Inc $23.98 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086716811 Novartis Pharmaceuticals Corporation $17.65 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086716813 Novartis Pharmaceuticals Corporation $21.24 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086716815 Novartis Pharmaceuticals Corporation $21.71 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092334883 Boston Scientific Corporation $20.95 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096607575 Novo Nordisk Inc $24.25 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096889310 Novo Nordisk Inc $124.78 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101289056 E.R. Squibb & Sons, L.L.C. $14.29 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101289068 E.R. Squibb & Sons, L.L.C. $21.69 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117876101 Boehringer Ingelheim Pharmaceuticals, Inc. $15.65 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117876103 Boehringer Ingelheim Pharmaceuticals, Inc. $19.64 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129427426 Esperion Therapeutics, Inc. $19.20 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130934157 PFIZER INC. $13.36 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130934482 PFIZER INC. $13.92 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130938282 PFIZER INC. $24.35 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.